Rare Diseases encompass a broad and diverse group of conditions that affect a relatively small number of people individually but collectively represent a significant global health challenge. Many rare diseases are genetic in origin and require highly specialised, multidisciplinary care for their diagnosis, treatment and long-term management.
Inherited Metabolic Disorders (IMDs) are an important group of rare genetic diseases caused by defects in metabolic pathways. These include conditions such as Phenylketonuria (PKU), in which the body is unable to properly metabolise phenylalanine. Early diagnosis, appropriate treatment and lifelong monitoring are essential to prevent complications and optimise patient outcomes.
The MedEA Academy activities in this therapeutic area focus on Rare Diseases, including Phenylketonuria (PKU), providing high-quality medical education to healthcare professionals involved in the multidisciplinary care of patients living with these conditions.